Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone for Prevention of Atrial Fibrillation Following Esophagectomy
NCT00420017Phase 4Completed
- Sponsor
- Indiana University
- Start
- Sep 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Indiana University. Primary endpoint: Incidence of Atrial Fibrillation at 7 days. Started Sep 2005; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00420017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420017.